Agios Pharmaceuticals (AGIO) Interest & Investment Income (2012 - 2023)
Agios Pharmaceuticals (AGIO) posted Interest & Investment Income of $8.3 million for Q2 2023, up 2.01% on a QoQ basis from $8.1 million in Q1 2023, and up 360.35% year-over-year from $1.8 million in Q2 2022.
Agios Pharmaceuticals (AGIO) Interest & Investment Income (2012 - 2023) Analysis & Trends
Agios Pharmaceuticals' Interest & Investment Income history runs 12 years deep, the most recent figure standing at $8.3 million for Q2 2023.
- Quarterly Interest & Investment Income rose 360.35% year-over-year to $8.3 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $26.7 million (up 766.7% YoY) and the FY2022 annual result came in at $12.8 million, up 1430.26% from the prior year.
- Interest & Investment Income was $8.3 million for Q2 2023 at Agios Pharmaceuticals, up from $8.1 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $8.3 million in Q2 2023 and bottomed at -$973000.0 in Q3 2020.
- A 5-year average of $3.0 million and a median of $2.9 million in 2019 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2020 — Interest & Investment Income slumped 133.7% — and 2022, when it surged 2048.91%.
- Agios Pharmaceuticals' Interest & Investment Income stood at $3.6 million in 2019, then surged by 71.84% to $6.1 million in 2020, then slumped by 94.6% to $332000.0 in 2021, then soared by 1854.22% to $6.5 million in 2022, then rose by 27.22% to $8.3 million in 2023.
- Business Quant data shows AGIO's Interest & Investment Income at $8.3 million in Q2 2023, $8.1 million in Q1 2023, and $6.5 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Agios Pharmaceuticals | 2.20 Bn | 1.46 Bn | 19.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 8.25 Mn |
| Mar 31, 2023 | 8.09 Mn |
| Dec 31, 2022 | 6.49 Mn |
| Sep 30, 2022 | 3.82 Mn |
| Jun 30, 2022 | 1.79 Mn |
| Mar 31, 2022 | 694,000.00 |
| Dec 31, 2021 | 332,000.00 |
| Sep 30, 2021 | 256,000.00 |
| Jun 30, 2021 | -92,000.00 |
| Mar 31, 2021 | 340,000.00 |
| Dec 31, 2020 | 6.15 Mn |
| Sep 30, 2020 | -973,000.00 |
| Jun 30, 2020 | 1.56 Mn |
| Mar 31, 2020 | 2.94 Mn |
| Dec 31, 2019 | 3.58 Mn |
| Sep 30, 2019 | 2.89 Mn |
| Jun 30, 2019 | 3.99 Mn |
| Mar 31, 2019 | 4.41 Mn |
| Dec 31, 2018 | 4.56 Mn |
| Sep 30, 2018 | 4.50 Mn |